BUZZ - Australia's Maas Group hits all-time high after Meta Firmus deal
路透社2026/09/29 02:31September 29 - **Real estate company Maas GroupMGH.AX shares rose as much as 3.2% to 7.090 Australian dollars, hitting a record high
** Artificial intelligence infrastructure company Firmus Technologies (Maas Group holds nearly 3.2% of its shares (link)) signed an agreement with Meta PlatformsMETA.O (link) to provide GPU computing power at its AI data centers
** Backed by Nvidia and with OpenAI as a key client, Firmus is preparing a $5 billion initial public offering (link)
** So far this year, MGH shares are up 29%
(To facilitate non-English speakers, Reuters provides automated translations of its reports into several other languages. As automated translations may be inaccurate or lack necessary context, Reuters does not guarantee the accuracy of these texts, which are provided solely for the convenience of readers. Reuters accepts no responsibility for any harm or loss arising from the use of automated translation functions.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Janus Henderson Macro Head Says Market Is Near Its Top but Cannot Say When
A $5.7 billion patent verdict has been issued, Burford Capital (BUR.US) may receive $1.4 billion, and its share price soared by more than 12%.
Burford Capital Ltd. surged more than 12% on Monday, marking its largest intraday increase since the end of March, after a federal jury delivered a verdict in a patent case involving Apple.
Pfizer (PFE.US), BioNTech (BNTX.US), and Moderna (MRNA.US) seek dismissal of Bayer’s Monsanto mRNA patent lawsuit, but the judge rejects the request
A federal judge in Delaware on Monday rejected the requests from Pfizer, BioNTech, and Moderna to dismiss a lawsuit filed against them by Monsanto, a subsidiary of the German pharmaceutical giant Bayer. The lawsuit concerns these pharmaceutical companies' use of a patent related to mRNA technology.
After years of waiting and another delay, Tesla (TSLA.US) postpones the Roadster debut to October 15 as severe weather forces the event to stop.
Tesla has rescheduled the unveiling event for its next-generation Roadster, originally planned for this week, to October 15.
Crypto prices
More
